Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid detection using non-radioactive labelling methods

E S Mansfield1, J M Worley, S E McKenzie

  • 1Molecular Dynamics, Inc., Sunnyvale, CA, USA.

Molecular and Cellular Probes
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibition.

Journal of thrombosis and haemostasis : JTH·2018
Same author

5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.

Journal of thrombosis and haemostasis : JTH·2017
Same author

CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes.

Journal of thrombosis and haemostasis : JTH·2014
Same author

The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer.

Oncogene·2013
Same author

MicroRNAs in platelet production and activation.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization.

Indian journal of human genetics·2010
Same journal

The CXCL9-CXCR3 axis mediates tumor progression and immune checkpoint regulation in colorectal cancer.

Molecular and cellular probes·2026
Same journal

Harnessing serum exosomal snoRNAs: A novel liquid biopsy approach for NSCLC diagnosis.

Molecular and cellular probes·2026
Same journal

Exosomes in celiac disease: From pathogenesis to diagnostic and therapeutic potential.

Molecular and cellular probes·2026
Same journal

MYLIP-dependent ubiquitination and degradation of LDLR in acute myeloid leukemia and MAPK signaling.

Molecular and cellular probes·2026
Same journal

The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma.

Molecular and cellular probes·2026
Same journal

First experiences in a US clinical laboratory with Oncomine Dx Express Test: Evaluation in formalin-fixed paraffin-embedded tissues.

Molecular and cellular probes·2026
See all related articles

Non-radioactive nucleic acid probes offer safer, more stable alternatives to traditional radioactive labels. These advanced probes enable diverse applications in genetic research and clinical diagnostics with improved detection methods.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Nucleic acid probe-based assays are essential tools in genetic research, forensics, and clinical diagnostics.
  • Traditional radioactive labels (e.g., 32P) present limitations including short shelf-life, safety concerns, and high disposal costs.

Purpose of the Study:

  • To review the desirable properties of nucleic acid probes.
  • To compare the advantages and disadvantages of various non-radioactive labeling strategies.
  • To showcase probe-based assays utilizing fluorescence detection.

Main Methods:

  • Review of existing literature on nucleic acid probe labeling techniques.
  • Analysis of different non-radioactive labeling methods (colorimetric, chemiluminescent, fluorescent).

Related Experiment Videos

  • Illustration of assay formats employing fluorescence scanning for detection.

    • Main Results:

    • Non-radioactive labeling strategies provide viable alternatives to radioactive probes.
    • Fluorescent probes facilitate sensitive detection in various assay formats.
    • General-purpose fluorescence scanners can be used for imaging probe-based assays.

    Conclusions:

    • Non-radioactive probes enhance the safety, stability, and applicability of nucleic acid assays.
    • Fluorescence-based detection offers a versatile and efficient method for probe assays.
    • Advancements in probe technology support broader use in research and clinical settings.